Advanced search
Publication Cover
Immunopharmacology and Immunotoxicology Volume 40, 2018 - Issue 4
Submit an article Journal homepage
144
Views
2
CrossRef citations to date
0
Altmetric
Brief Communication

A new sight for paraquat poisoning from immunology

Qiang WuDepartments of Poisoning and Occupational Diseases, Qilu Hospital, Shandong University, Jinan, Shandong, P.R. China; ;Department of Intensive Care Medicine, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, P.R. China; ORCID Iconhttp://orcid.org/0000-0001-9704-5317View further author information
ORCID Icon,
Qinliang XuDepartments of Poisoning and Occupational Diseases, Qilu Hospital, Shandong University, Jinan, Shandong, P.R. China; View further author information
,
Xiangdong JianDepartments of Poisoning and Occupational Diseases, Qilu Hospital, Shandong University, Jinan, Shandong, P.R. China; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-2277-6817View further author information
ORCID Icon,
Huaxue WangDepartment of Intensive Care Medicine, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, P.R. China; View further author information
,
Xiandi HeDepartment of Intensive Care Medicine, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, P.R. China; View further author information
,
Beijun GaoDepartments of Poisoning and Occupational Diseases, Qilu Hospital, Shandong University, Jinan, Shandong, P.R. China; View further author information
,
Ke WangPublic Health School of Shandong University, Jinan, Shandong, P.R. ChinaView further author information
&
Baotian KanDepartments of Poisoning and Occupational Diseases, Qilu Hospital, Shandong University, Jinan, Shandong, P.R. China; View further author information
 show all
Pages 269-272 | Received 02 Feb 2018, Accepted 16 May 2018, Published online: 24 Jul 2018

References

  • Weng CH, Hu CC, Lin JL, et al. Sequential organ failure assessment score can predict mortality in patients with paraquat intoxication. PLoS One. 2012;7:e51743.
  • Smith P, Heath D. The pathology of the lung in paraquat poisoning. J Clin Pathol Suppl (R Coll Pathol). 1975;9:81–93.
  • Riahi B, Rafatpanah H, Mahmoudi M, et al. Evaluation of suppressive effects of paraquat on innate immunity in Balb/c mice. J Immunotoxicol. 2011;8:39–45.
  • Ma J, Li Y, Niu D, et al. Immunological effects of paraquat on common carp, Cyprinus carpio L. Fish Shellfish Immunol. 2014;37:166–172.
  • Hu L, Yu Y, Huang H, et al. Epigenetic regulation of interleukin 6 by histone acetylation in macrophages and its role in paraquat-induced pulmonary fibrosis. Front Immunol. 2017;7:696.
  • Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 2016;44:450–462.
  • Wu WP, Lai MN, Lin CH, et al. Addition of immunosuppressive treatment to hemoperfusion is associated with improved survival after paraquat poisoning: a nationwide study. PLoS One. 2014;9:e87568.
  • Zhang J, Zhao Y, Bai Y, et al. The significance of serum uric acid level in humans with acute paraquat poisoning. Sci Rep. 2015;5:9168.
  • Gasse P, Riteau N, Charron S, et al. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am J Respir Crit Care Med. 2009;179:903–913.
  • Tsai JL, Chen CH, Wu MJ, et al. Paraquat poisoning in patients with HIV infection: A case report and literature review. Medicine (Baltimore). 2016;95:e3350.
  • Rose MS, Lock EA, Smith LL, et al. Paraquat accumulation: tissue and species specificity. Biochem Pharmacol. 1976;25:419–423.
  • Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10:826–837.
  • Hara Y, Shimomura Y, Nakamura T, et al. Novel blood purification system for regulating excessive immune reactions in severe sepsis and septic shock: an ex vivo pilot study. Ther Apher Dial. 2015;19:308–315.
  • Dignass A, Akbar A, Hart A, et al. Safety and efficacy of granulocyte/monocyte apheresis in steroid-dependent active ulcerative colitis with insufficient response or intolerance to immunosuppressants and/or biologics [the ART Trial]: 12-week interim results. J Crohns Colitis. 2016;10:812–820.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.